These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21941527)

  • 21. Coexistence of hyper-uricaemia and low urinary uric acid excretion further increases risk of chronic kidney disease in type 2 diabetes.
    Chen MY; Wang AP; Wang JW; Ke JF; Yu TP; Li LX; Jia WP
    Diabetes Metab; 2019 Dec; 45(6):557-563. PubMed ID: 30928248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):577-81. PubMed ID: 16320155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
    Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
    Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study.
    Lee JJ; Yang IH; Kuo HK; Chung MS; Chen YJ; Chen CH; Liu RT
    Diabetes Res Clin Pract; 2014 Nov; 106(2):366-72. PubMed ID: 25108898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
    Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
    Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum uric acid and diabetic peripheral neuropathy: a double-edged sword.
    Zhuang Y; Huang H; Hu X; Zhang J; Cai Q
    Acta Neurol Belg; 2023 Jun; 123(3):857-863. PubMed ID: 35643885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum uric acid is independently associated with diabetic nephropathy but not diabetic retinopathy in patients with type 2 diabetes mellitus.
    Xia Q; Zhang SH; Yang SM; Zhu XL; Su S; Hu AP; Zhu J; Li DM
    J Chin Med Assoc; 2020 Apr; 83(4):350-356. PubMed ID: 32132382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China.
    Ren Y; Gao L; Guo X; Huo X; Lu J; Li J; Ji L; Yang X
    J Diabetes Complications; 2018 Nov; 32(11):1000-1005. PubMed ID: 30224234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid and diabetes: Is there a link?
    Katsiki N; Papanas N; Fonseca VA; Maltezos E; Mikhailidis DP
    Curr Pharm Des; 2013; 19(27):4930-7. PubMed ID: 23278493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of serum uric acid with canagliflozin monotherapy in type 2 diabetes: A potential link between uric acid and pancreatic β-cell function
.
    Kutoh E; Wada A; Kuto AN; Hayashi J
    Int J Clin Pharmacol Ther; 2019 Dec; 57(12):590-595. PubMed ID: 31587751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus.
    Ishibashi F; Kojima R; Kawasaki A; Yamanaka E; Kosaka A; Uetake H
    J Diabetes Investig; 2014 Sep; 5(5):588-96. PubMed ID: 25411628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes.
    Sheikhbahaei S; Fotouhi A; Hafezi-Nejad N; Nakhjavani M; Esteghamati A
    Metab Syndr Relat Disord; 2014 Mar; 12(2):102-9. PubMed ID: 24447037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between fasting C-peptide and serum uric acid in patients with type 2 diabetes mellitus].
    Liang Q; Wang XY; Hu HF; Lai JB; Yao WL; Chen ML; Rao X
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):490-495. PubMed ID: 29735453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients.
    Fouad M; Fathy H; Zidan A
    J Bras Nefrol; 2016 Dec; 38(4):403-410. PubMed ID: 28001185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):122-5. PubMed ID: 20690070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
    J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes.
    Chen MY; Zhao CC; Li TT; Zhu Y; Yu TP; Bao YQ; Li LX; Jia WP
    Sci Rep; 2017 Jan; 7():40009. PubMed ID: 28051185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
    Miao Y; Ottenbros SA; Laverman GD; Brenner BM; Cooper ME; Parving HH; Grobbee DE; Shahinfar S; de Zeeuw D; Lambers Heerspink HJ
    Hypertension; 2011 Jul; 58(1):2-7. PubMed ID: 21632472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
    Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
    Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients.
    Hu Y; Chan Z; Li C; Shi Y; She X; Gu C; Wang Y; Zhou C; Zhao S; Zheng Z; Chen H
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):23. PubMed ID: 33861320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.